Correction

Published on 18 Nov 2024

Corrigendum: The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study

in Cancer Immunity and Immunotherapy

Juhina Das
Saurav Bera
Nilanjan Ganguly
Ipsita Guha
Tithi Ghosh Halder
Avishek Bhuniya
Partha Nandi
Mohona Chakravarti
Sukanya Dhar
Anirban Sarkar

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470330

221 views

Original Research

Published on 18 Nov 2024

Long term survival and outcomes in patients with paraneoplastic neurologic syndromes

in Cancer Immunity and Immunotherapy

Sapir Bar Mucha
Ayal Rozenberg
Lilach Gutter Kapon
Alon Gorenshtein
Esther Ganelin-Cohen
Rachel Ben Hayun
Nataliya Yarovinsky
Shahar Shelly

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466704

312 views

Original Research

Accepted on 15 Nov 2024

Prognostic significance of hemoglobin, albumin, lymphocyte and platelet score in solid tumors: A systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Jinze Li
Jing Zheng
Puze Wang
Dong Lv

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483855

115 views

Original Research

Accepted on 15 Nov 2024

Circulating immune landscape in melanoma patients undergoing anti-PD1 therapy reveals key immune features according to clinical response to treatment

in Cancer Immunity and Immunotherapy

Eleonora Sosa Cuevas
Stéphane Mouret
Guillaume Vayssière
Siham Kerboua
Pauline Girard
Jean-Paul Molens
Marc Monceau
Julie Charles
Philippe Saas
CAROLINE ASPORD

Frontiers in Immunology

doi 10.3389/fimmu.2024.1507938

125 views

Review

Accepted on 15 Nov 2024

From Tumor Microenvironment to Emerging Biomarkers: The Reshaping of the Esophageal Squamous Cell Carcinoma Tumor Microenvironment by Neoadjuvant Chemotherapy Combined with Immunotherapy

in Cancer Immunity and Immunotherapy

Zhengzhou Qiu
Changying Guo
Zhao Li
Xingfei Liu
Ruilin Zhang
Yongxuan Li
Yin Bao
Chenggen Gao
Xiaoling Mao
Mingyue Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478922

Case Report

Published on 15 Nov 2024

Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

in Cancer Immunity and Immunotherapy

Muyang Chen
Anpeng Wang
Hao Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1464900

224 views

Original Research

Published on 15 Nov 2024

Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023

in Cancer Immunity and Immunotherapy

Yiwen Bao
Zeming Mo
Shuang Wang
Jinhua Long
Honghong Zhang
Yujun Xu
Honglian Jiang
Tianbao Qian
Zhu Zeng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1475062

288 views

Case Report

Published on 15 Nov 2024

Case report: CD7-targeted autologous CAR-T therapy for the treatment of T-cell acute lymphoblastic leukemia undergoing allogeneic peripheral blood stem cell transplantation in the long-term follow-up

in Cancer Immunity and Immunotherapy

Lian-Lian Li
Yue-Ping Xia
Qianqian Li
Peng Wang
Ping-Ping Sun
Xing-Guang Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1469251

279 views

Original Research

Published on 15 Nov 2024

The clinical and pathological significance of tertiary lymphoid structure in extramammary Paget's disease

in Cancer Immunity and Immunotherapy

Ningyuan Xi
Xiaoxiang Xu
Mingyuan Xu
Nanhui Wu
Yuhao Wu
Jiashe Chen
Shuyi Liu
Long Jiang
Guorong Yan
Guolong Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1435629

144 views

Correction

Published on 15 Nov 2024

Corrigendum: Unraveling the ecological landscape of mast cells in esophageal cancer through single-cell RNA sequencing

in Cancer Immunity and Immunotherapy

Shengyi Zhang
Xinyi Zhang
Zhikai Xiahou
Shunqing Zuo
Jialong Xue
Yi Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1522632

151 views

Original Research

Published on 15 Nov 2024

The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy

in Cancer Immunity and Immunotherapy

Amandine Decroos
Sarah Meddour
Marine Demoy
Nathalie Piccirilli
Philippe Rousselot
Franck E. Nicolini
Stéphanie Ragot
Jean-Marc Gombert
André Herbelin
Alice Barbarin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1473139

324 views

Review

Published on 15 Nov 2024

Prospects of anti-GD2 immunotherapy for retinoblastoma

in Cancer Immunity and Immunotherapy

Xinlong Zhang
Wulin You
Yuntao Wang
Rebeka Dejenie
Chenhao Wang
Yan Huang
Jingjing Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1499700

223 views

Review

Published on 15 Nov 2024

The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications

in Cancer Immunity and Immunotherapy

Xiaohong Duan
Zhiyao Xing
Lu Qiao
Shan Qin
Xuejing Zhao
Yanhua Gong
Xueren Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495221

366 views

Original Research

Accepted on 14 Nov 2024

Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression

in Cancer Immunity and Immunotherapy

Oanh T. P. Nguyen
Sandra Lara
Giovanni Ferro
Matthias Peipp
Sandra Kleinau

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483617

100 views

Original Research

Accepted on 14 Nov 2024

Comparison of Lenvatinib plus Pembrolizumab versus First-line Systemic Chemotherapy for Advanced Intrahepatic Cholangiocarcinoma: A Real-World Retrospective Study

in Cancer Immunity and Immunotherapy

Zhenyun Yang
Weijie Wu
Zhiwen Hu
Yizhen Fu
Zili Hu
Yang-Xun Pan
Juncheng Wang
Jinbin Chen
Zhongguo Zhou
Yaojun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494520

Original Research

Accepted on 14 Nov 2024

Research on the Influence of Radiotherapy-Related Genes on Immune Infiltration, Immunotherapy Response and Prognosis in Melanoma based on multi-omics

in Cancer Immunity and Immunotherapy

Yujing Shi
Wantong Zhao
Yuanjian Ding
Xiaolin Ge
Mengyang Ju

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467098

Navigation group

Articles

Corrigendum: The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study

Long term survival and outcomes in patients with paraneoplastic neurologic syndromes

Prognostic significance of hemoglobin, albumin, lymphocyte and platelet score in solid tumors: A systematic review and meta-analysis

Circulating immune landscape in melanoma patients undergoing anti-PD1 therapy reveals key immune features according to clinical response to treatment

From Tumor Microenvironment to Emerging Biomarkers: The Reshaping of the Esophageal Squamous Cell Carcinoma Tumor Microenvironment by Neoadjuvant Chemotherapy Combined with Immunotherapy

Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023

Case report: CD7-targeted autologous CAR-T therapy for the treatment of T-cell acute lymphoblastic leukemia undergoing allogeneic peripheral blood stem cell transplantation in the long-term follow-up

The clinical and pathological significance of tertiary lymphoid structure in extramammary Paget's disease

Corrigendum: Unraveling the ecological landscape of mast cells in esophageal cancer through single-cell RNA sequencing

The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy

Prospects of anti-GD2 immunotherapy for retinoblastoma

The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications

Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression

Comparison of Lenvatinib plus Pembrolizumab versus First-line Systemic Chemotherapy for Advanced Intrahepatic Cholangiocarcinoma: A Real-World Retrospective Study

Research on the Influence of Radiotherapy-Related Genes on Immune Infiltration, Immunotherapy Response and Prognosis in Melanoma based on multi-omics